Bullboard - Stock Discussion Forum Aptorum Group Ltd APM

Healthcare Biotechnology

Aptorum Group Limited is a United Kingdom-based clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which... see more

Add To Watchlist

NDAQ:APM - Post Discussion

Aptorum Group Ltd > Aptorum Group Ltd Announces Entering into an Agreement and P

View:

Post by whytestocks on Mar 06, 2024 11:00am

Aptorum Group Ltd Announces Entering into an Agreement and P

JUST IN: $APM Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy BusinessAptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company ( “Aptorum” ), and privately-held YOOV Group Holding Ltd. ( “YOOV” ) jointly announced today that they entered into an Agreement and Plan of Merger (as it may be amended from time t...APM - Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business